Carlsmed, Inc.
CARL
$14.50
$0.050.35%
NASDAQ
03/31/2025 | 03/31/2024 | ||||
---|---|---|---|---|---|
Revenue | 10.19M | 5.09M | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 10.19M | 5.09M | |||
Cost of Revenue | 2.55M | 1.42M | |||
Gross Profit | 7.64M | 3.66M | |||
SG&A Expenses | 10.21M | 5.74M | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 15.91M | 10.42M | |||
Operating Income | -5.72M | -5.33M | |||
Income Before Tax | -5.73M | -5.45M | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -5.73M | -5.45M | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -5.73M | -5.45M | |||
EBIT | -5.72M | -5.33M | |||
EBITDA | -5.68M | -5.29M | |||
EPS Basic | -0.26 | -0.24 | |||
Normalized Basic EPS | -0.15 | -0.15 | |||
EPS Diluted | -0.26 | -0.24 | |||
Normalized Diluted EPS | -0.15 | -0.15 | |||
Average Basic Shares Outstanding | 23.99M | 22.30M | |||
Average Diluted Shares Outstanding | 23.99M | 22.30M | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |